참고문헌
- Andersen J (1996). Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol, 14, 269-82. https://doi.org/10.1055/s-2007-1016336
- Barakat RR, Park RC, Grigsby PW, et al (1997). Corpus:epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and practice of gynecologic oncology. 2nd ed. Philadelphia: Lippincott-Raven, 859-96.
- Barnes MN, Kilgore LC (2000). Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol, 10, 3-7. https://doi.org/10.1016/S1053-4296(00)80014-4
- Binesh F, Akhavan A, Behniafard N, et al (2014). Endometrial adenocarcinoma: clinicopathologic and survival characteristics in Yazd, Iran. Asian Pac J Cancer Prev, 15, 2797-801. https://doi.org/10.7314/APJCP.2014.15.6.2797
- Chan JK, Sherman AE, Kapp DS, et al (2011). Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol, 29, 832-8. https://doi.org/10.1200/JCO.2010.31.2124
- Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer. Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, france: international agency for research on cancer.
- Fortuny J, Sima C, Bayuga S, et al (2009). Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev, 18, 1448-56. https://doi.org/10.1158/1055-9965.EPI-08-0936
- Horwitz RI, Horwitz SM, Feinstein R, et al (1981). Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies. Lancet, 2, 66-8.
- Howlader N, Noone AM, Krapcho M, et al (2013). SEER cancer statistics review, 1975-2011 based on November 2013 SEER data submission. National Cancer Institute. Bethesda, MD.
- Koss L, Schreiber K, Oberlander S, et al (1981). Screening of asymptomatic women for endometrial cancer. CA Cancer J Clin, 31, 300-17. https://doi.org/10.3322/canjclin.31.5.300
- Lim YK, Padma R, Foo L, et al (2011). Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study. J Gynecol Oncol, 22, 239-43. https://doi.org/10.3802/jgo.2011.22.4.239
- Manchana T, Khemapech N (2008). Endometrial adenocarcinoma in young Thai women. Asian Pac J Cancer Prev, 9, 283-6.
- Ouldamer L, Rossard L, Arbion F, et al (2014). Risk of incidental finding of endometrial cancer at the time of hysterectomy for benign condition. J Minim Inv Gynecol, 21, 131-5. https://doi.org/10.1016/j.jmig.2013.08.002
- Rein MS, Barbieri RL, Friedman AJ (1995). Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol, 172, 14-8. https://doi.org/10.1016/0002-9378(95)90077-2
- Smith-Bindman R, Kerlikowske K, Feldstein V, et al (1998). Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA, 280, 1510-7.
- Srisomboon J, Phongnarisorn C, Suprasert P (2001). Endometrial cancer diagnosed in patients undergoing hysterectomy for benign gynecologic conditions. Thai J Obstet Gynaecol, 13, 29-32.
- Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, et al (2010). Endometrial cancer in thai women: clinicopathological presentation and survival. Asian Pacific J Cancer Prev, 11, 1267-72.
- Zaino R, Whitney C, Brady MF, et al (2001). Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol, 83, 355-62. https://doi.org/10.1006/gyno.2001.6400
- Zimmermann A, Bernuit D, Gerlinger C, et al (2012). Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women's Health, 12, 6. https://doi.org/10.1186/1472-6874-12-6
피인용 문헌
- Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women vol.178, pp.9, 2018, https://doi.org/10.1001/jamainternmed.2018.2820